Search Results
10
Everything
Search Filters
Organization
Embecta Corp.
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations
April 01, 2025 08:05 ET
|
Embecta Corp.
The FITTER Forward Expert Recommendations are an updated set of global best practices for insulin injection technique and education.
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference
February 18, 2025 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial Officer, will present at the J.P. Morgan...
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results
February 06, 2025 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month...
embecta Announces Quarterly Cash Dividend
February 06, 2025 06:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
embecta to Report Fiscal First Quarter 2025 Financial Results
January 23, 2025 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on...
Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs
November 26, 2024 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and...
embecta Announces Quarterly Cash Dividend
November 26, 2024 06:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding...
UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
November 12, 2024 17:31 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
November 12, 2024 17:00 ET
|
Embecta Corp.
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call...